On August 22, 2014, BioCube, Inc. entered into an agreement with IUT Medical GmbH to form a USA-based joint venture entity for the purposes of commercialization the Marijuana Breath Analyzing Device being developed by IUT-M on the basis of already existing systems offered by IUT-M. The specific terms of the agreement are as follows: JV will receive ownership and world-wide license to the device from IUT-M. BioCube ownership in JV is 51%. IUT-M ownership in JV is 49%. IUT-M is entitled to 2.5% royalty payments on products sold by JV.

IUT-M will receive 1,000,000 shares of BioCube, currently trading on OTC Stock Exchange. JV to be transition into a standalone public entity through spin-off in 9 to 18 months after the initial product sales.